Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?
about
Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat StrainAberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure?Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion.Relation of coronary collateral circulation with epicardial fat volume in patients with stable coronary artery disease.Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.Application of ischemic postconditioning's algorithms in tissues protection: response to methodological gaps in preclinical and clinical studies.PPARγ activation inhibits cerebral arteriogenesis in the hypoperfused rat brain.Impaired coronary collateral growth in the metabolic syndrome is in part mediated by matrix metalloproteinase 12-dependent production of endostatin and angiostatin.Coronary collateral circulation in patients with chronic coronary total occlusion; its relationship with cardiac risk markers and SYNTAX score.Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion.Lower vitamin D level is associated with poor coronary collateral circulation.Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction.Fibroblast-Specific Deletion of Hypoxia Inducible Factor-1 Critically Impairs Murine Cutaneous Neovascularization and Wound Healing.Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.
P2860
Q28066227-A1CD56AA-F10D-4067-8E98-3D525BD51D20Q30642656-9E7A9D64-1942-447F-B0F8-DDF7AE37885BQ34478974-B6A1C58C-BB13-4E67-B35A-DA10DBC787C5Q35786497-569EA1B1-BDD1-44E0-BF75-A9159A3C42F1Q37076603-30E2FEA2-DA4B-44DB-9A3E-EBE240655648Q37466716-38FAFEFE-E266-44A9-8D92-F6647719D8E3Q38185249-8E564C10-0EC0-49FB-83BA-69509D342768Q38731425-12E69913-9362-43B3-A5CA-449B2ADE9590Q40143324-6CF04963-13E8-4828-BBF4-23EB19FDFC7EQ42571891-1A2B1216-B546-40B6-AC69-CC61CA686660Q48470370-E335B577-BA28-4BAA-BE85-EA8FB53E9A40Q49220874-C6A4142C-451F-4BFD-B3FE-A164ACC8A81BQ51130809-F5202F8C-3C4C-42CC-9C22-C36FE191ABA0Q51239324-FF2F609E-E857-4FD4-8B89-26E8BB3349A5Q53298814-D1289416-B8E9-420E-8B5C-821ED5313F2FQ55297470-C1BC7041-77E2-489C-A06F-98DDE267C12A
P2860
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Why is coronary collateral gro ...... es and the metabolic syndrome?
@ast
Why is coronary collateral gro ...... es and the metabolic syndrome?
@en
Why is coronary collateral gro ...... es and the metabolic syndrome?
@nl
type
label
Why is coronary collateral gro ...... es and the metabolic syndrome?
@ast
Why is coronary collateral gro ...... es and the metabolic syndrome?
@en
Why is coronary collateral gro ...... es and the metabolic syndrome?
@nl
prefLabel
Why is coronary collateral gro ...... es and the metabolic syndrome?
@ast
Why is coronary collateral gro ...... es and the metabolic syndrome?
@en
Why is coronary collateral gro ...... es and the metabolic syndrome?
@nl
P2860
P3181
P1476
Why is coronary collateral gro ...... es and the metabolic syndrome?
@en
P2093
Petra Rocic
P2860
P304
P3181
P356
10.1016/J.VPH.2012.02.001
P407
P577
2012-01-01T00:00:00Z